Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


First Quarter 2008 Financial Results Announcement and Teleconference

    PHILADELPHIA, April 16 /PRNewswire-FirstCall/ -- On Wednesday, April
23, 2008, GlaxoSmithKline plc will announce its first quarter financial
results for the three months ended March 31, 2008. The announcement is
scheduled to be released to the London Stock Exchange at approximately 7:00
am (ET) US and will be available on the website: http://www.gsk.com shortly
thereafter.

    Following the announcement, JP Garnier, Chief Executive Officer and
Julian Heslop, Chief Financial Officer, will hold a global teleconference
for analysts and investors. You are invited to listen in to this
presentation of the first quarter 2008 results. This teleconference will
take place on:


Wednesday, April 23rd at 9:00 am ET To participate in the teleconference please dial: U.S. Toll Free Phone +1 877 491 0064 Please quote: GSK Q1 Results A recording of the teleconference will be available from 1:00 pm ET on April 23rd (until April 30th) on: U.S. Toll Free phone + 1 888 365 0240 Passcode: 792110 GSK will host a live audio webcast of the results presentation with synchronized slides. It will begin at the same time as the teleconference, 9:00 am ET, and can be accessed directly via the GlaxoSmithKline website: http://gsk.com. Slides will be available shortly before the teleconference on the GSK website. An archived version of this webcast will be available from the corporate website at approximately 3:00 pm ET on the same day.
SOURCE GlaxoSmithKline plc




Back to Topback to top

Related links:
  • http://www.gsk.com
  • http://www.prnewswire.com/comp/801350.html /
    CONTACT:
    US Media inquiries, Nancy Pekarek, +1-215-751
    7709, or Mary Anne Rhyne +1-919-483-2839, US Analyst, Investor
    inquiries, Frank Murdolo, +1-215-751-7002, or Tom Curry,
    +1-215-751-5419, all of GlaxoSmithKline plc